{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:37:51Z","timestamp":1762270671859},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1989,6,1]],"date-time":"1989-06-01T00:00:00Z","timestamp":612662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1989,6]]},"DOI":"10.1007\/bf00435836","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T09:58:10Z","timestamp":1100167090000},"page":"358-362","source":"Crossref","is-referenced-by-count":28,"title":["Phase I trial of combined therapy with bleomycin and the calmodulin antagonist, trifluoperazine"],"prefix":"10.1007","volume":"23","author":[{"given":"William N.","family":"Hait","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Lazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Figlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry J.","family":"Durivage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter E.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N","volume":"31","author":"RH Blum","year":"1973","unstructured":"Blum RH, Carter SK, Agve K (1973) A clinical review of bleomycin?a new antineoplastic agent. Cancer 31:903","journal-title":"Cancer"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0006-291X(80)90849-9","volume":"95","author":"AL Boynton","year":"1980","unstructured":"Boynton AL, Whitfield JF, MacManus JP (1980) Calmodulin stimulates DNA synthesis in rat liver cells. Biochem Biophys Res Commun 95:745","journal-title":"Biochem Biophys Res Commun"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0190-9622(87)70004-8","volume":"16","author":"IM Braverman","year":"1987","unstructured":"Braverman IM, Yager NB, Chen M, Cadman EC, Hait WN, Maynard T (1987) Combined total body electron beam irradiation and chemotherapy for mycosis fungoides. J Am Acad Dermatol 16:45","journal-title":"J Am Acad Dermatol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.6203171","volume":"224","author":"JA Chafouleas","year":"1984","unstructured":"Chafouleas JA, Bolton WE, Means AR (1984) Potentiation of bleomycin lethality by anticalmodulin drugs: a role for calmodulin in DNA repair. Science 224:1346","journal-title":"Science"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1126\/science.6243188","volume":"207","author":"WY Cheung","year":"1980","unstructured":"Cheung WY (1980) Calmodulin plays a pivotal role in cellular regulation. Science 207:19","journal-title":"Science"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-5793(78)80772-8","volume":"92","author":"P Cohen","year":"1978","unstructured":"Cohen P, Burchill A, Foulkes JG, Cohen PTW, Vanaman TC, Narin AC (1978) Identification of the Ca-dependent modulator protein as the fourth subunit of rabbit skeletal muscle phosphorylase kinase. FEBS Lett 92:287","journal-title":"FEBS Lett"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-98-3-304","volume":"98","author":"RI Fisher","year":"1983","unstructured":"Fisher RI, DeVita VT Jr, Hubbard SM, Longo DL, Wesley R, Chabner B, Young RC (1983) Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of Pro-MACE and MOPP chemotherapy. Ann Intern Med 98:304","journal-title":"Ann Intern Med"},{"key":"CR8","first-page":"3696","volume":"43","author":"R Ganapathi","year":"1983","unstructured":"Ganapathi R, Grabowski D (1983) Enhancement of sensitivity to adriamycin in resistant P 388 leukemia by the calmodulin inhibitor trifluoperazine. Cancer Res 43:3696","journal-title":"Cancer Res"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0006-291X(77)80107-1","volume":"17","author":"RM Gopinath","year":"1977","unstructured":"Gopinath RM, Vincenzi FF (1977) Phosphodiesterase protein activator mimics red blood cell cytoplasmic activator of Ca2+-Mg2+-ATPase. Biochem Biophys Res Commun 17:1203","journal-title":"Biochem Biophys Res Commun"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.1986.4.6.994","volume":"4","author":"WN Hait","year":"1986","unstructured":"Hait WN, Lazo JS (1986) Calmodulin: a potential target for cancer chemotherapeutic agents. J Clin Oncol 4:994","journal-title":"J Clin Oncol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1016\/0006-2952(85)90374-0","volume":"34","author":"WN Hait","year":"1985","unstructured":"Hait WN, Lee GL (1985) Characterization of the cytotoxic effects of the phenothiazine class of calmodulin antagonists. Biochem Pharmacol 34:3973?3978","journal-title":"Biochem Pharmacol"},{"key":"CR12","first-page":"202","volume":"14","author":"WN Hait","year":"1985","unstructured":"Hait WN, Grais L, Benz C, Cadman EC (1985) Inhibition of growth of leukemic cells by inhibitors of calmodulin: phenothiazines and melittin. Cancer Chemother Pharmacol 14:202","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/jnci\/80.4.246","volume":"80","author":"WN Hait","year":"1988","unstructured":"Hait, WN, Lazo JS, Chen D-L, Gallichio VS, Filderman AE (1988) Antitumor and toxic effects of combination chemotherapy with bleomycin and a phenothiazine anticalmodulin agent. J Natl Cancer Inst 80:246","journal-title":"J Natl Cancer Inst"},{"key":"CR14","first-page":"409","volume-title":"Human tumor cloning","author":"RA Hickie","year":"1984","unstructured":"Hickie RA, Klaassen DJ, Carl GZ, Meyskens FL Jr, Kreutzfeld KL, Thomson SP (1984) Anticalmodulin agents as inhibitors of human tumor cell clonogenicity. In: Salmon SE, Trent JM (eds) Human tumor cloning. Grune & Stratton, New York, p 409"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0006-291X(77)80108-3","volume":"71","author":"HW Jarrett","year":"1977","unstructured":"Jarrett HW, Penniston JT (1977) Partial purification of the Ca2+-Mg2+-ATPase activator from human erythrocytes: its similarity to the activator of 3?,5?-cyclic nucleotide phosphodiesterase. Biochem Biophys Res Commun 71:1210","journal-title":"Biochem Biophys Res Commun"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0014-4827(82)90094-5","volume":"138","author":"A Jones","year":"1982","unstructured":"Jones A, Boynton AL, MacManus JP, Whitfield JF (1982) Ca2+-calmodulin mediates the DNA-synthetic response of calcium-deprived liver cells to the tumor promoter TPA. Exp Cell Res 138:87","journal-title":"Exp Cell Res"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/0360-3016(86)90173-2","volume":"12","author":"KA Kennedy","year":"1986","unstructured":"Kennedy KA, Hait WN, Lazo JS (1986) Chemical modulation of bleomycin induced toxicity. Int J Radiat Biol Biophys 12: 1367","journal-title":"Int J Radiat Biol Biophys"},{"key":"CR18","first-page":"387","volume":"27","author":"JS Lazo","year":"1985","unstructured":"Lazo JS, Hait WN, Kennedy KA, Braun ID, Meandzija B (1985) Enhanced bleomycin-induced DNA damage and cytotoxicity with calmodulin antagonists. Mol Pharmacol 27:387","journal-title":"Mol Pharmacol"},{"key":"CR19","first-page":"2236","volume":"46","author":"JS Lazo","year":"1986","unstructured":"Lazo JS, Chen D-L, Gallicchio VS, Hait WN (1986) Increased lethality of calmodulin antagonists and bleomycin to human bone marrow and bleomycin-resistant malignant cells. Cancer Res 46:2236","journal-title":"Cancer Res"},{"key":"CR20","first-page":"347","volume":"36","author":"GL Lee","year":"1984","unstructured":"Lee GL, Hait WN (1984) Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulin. Life Sci 36:347","journal-title":"Life Sci"},{"key":"CR21","first-page":"581","volume":"12","author":"RM Levin","year":"1976","unstructured":"Levin RM, Weiss B (1976) Mechanisms by which psychotropic drugs inhibit adenosine cyclic 3?,5?-monophosphate phosphodiesterase of brain. Mol Pharmacol 12:581","journal-title":"Mol Pharmacol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-93-4-533","volume":"93","author":"JS MacDonal","year":"1980","unstructured":"MacDonal JS, Schein PS, Wooley PV, Smythe T, Winston U, Hoth D, Frederick S, Boiron M, Gisselbrecht C, Brunet R, Lagarde C (1980) 5-Fluorouracil, mitomycin-C and adriamycin (FAM): a new combination chemotherapy program for advanced gastric carcinoma. Ann Intern Med 93:533","journal-title":"Ann Intern Med"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1073\/pnas.75.8.3771","volume":"75","author":"JM Marcum","year":"1978","unstructured":"Marcum JM, Dedman JR, Brinkley BR, Means AR (1978) Control of microtubule assembly0disassembly by the calcium-dependent regulator protein. Proc Natl Acad Sci USA 75: 3771","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR24","first-page":"307","volume-title":"Gene regulation. UCLA Symposium on Molecular and Cellular Biology","author":"AR Means","year":"1982","unstructured":"Means AR, Chafouleas JA, Lagace L, Lai E, Stein JP (1982) Multiple roles for calmodulin in the regulation of eukaryotic cell metabolism. In: O'Malley (ed) Gene regulation. UCLA Symposium on Molecular and Cellular Biology. Academic Press, New York, p 307"},{"key":"CR25","volume-title":"Neuroleptics, neurochemistry, behavioral and clinical response","author":"HY Meltzer","year":"1983","unstructured":"Meltzer HY, Kare JM, Kolakowskat T (1983) Plasma levels of neuroleptics, prolactin levels, and clinical response. In: Coyle T, Enna JJ (eds) Neuroleptics, neurochemistry, behavioral and clinical response. Raven Press, New York"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1200\/JCO.1988.6.5.880","volume":"6","author":"RL Miller","year":"1987","unstructured":"Miller RL, Bukowski RM, Budd GT, Purvis J, Weick JK, Shepard K, Midha KK, Ganapathi R (1987) Clinical modulation of doxorubicin resistance by the calmodulin inhibitor, trifluoperazine: a phase I\/II trial. J Clin Oncol 6:880?888","journal-title":"J Clin Oncol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1073\/pnas.75.11.5432","volume":"75","author":"H Schulman","year":"1978","unstructured":"Schulman H, Greengard P (1978) Ca2+-dependent protein phosphorylation system in membranes from various tissues and its activation by ?calcium-dependent regulator?. Proc Natl Acad Sci USA 75:5432","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR28","first-page":"1967","volume":"41","author":"T Tsuruo","year":"1981","unstructured":"Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil Cancer Res 41:1967","journal-title":"Cancer Res"},{"key":"CR29","first-page":"86","volume":"11","author":"JW Wei","year":"1983","unstructured":"Wei JW, Hickie RA, Klassen DJ (1983) Inhibition of human breast cancer colony formation by anti-calmodulin agents: trifluoperazine, W-7, and W-13. Cancer Chemother Pharmacol 11:86","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/0006-291X(82)91272-4","volume":"106","author":"SD Yang","year":"1982","unstructured":"Yang SD, Tallant EA, Cheung WY (1982) Calcineurin is a calmodulin-dependent protein phosphatase. Biochem Biophys Res Commun 106:1419","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00435836.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00435836\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00435836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T23:11:30Z","timestamp":1554851490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00435836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1989,6]]}},"alternative-id":["BF00435836"],"URL":"https:\/\/doi.org\/10.1007\/bf00435836","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,6]]}}}